Literature DB >> 6511883

Rapid determination of 5-fluorocytosine levels in blood.

M A Noble, B Harper, A G Grant, M Bernstein.   

Abstract

Levels of 5-fluorocytosine in blood were rapidly calculated by determining the amount of competition in the creatinine iminohydrolase (creatinine deiminase; EC 3.5.4.21) assay for creatinine with the Kodak Ektachem system (Eastman Kodak Co., Rochester, N.Y.). The correlation with bioassay values was extremely high (r = 0.982). Standards and samples were highly stable over time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511883      PMCID: PMC271494          DOI: 10.1128/jcm.20.5.996-997.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Fluorometric measurement of 5-fluorocytosine in biological fluids.

Authors:  D Wade; G Sudlow
Journal:  J Pharm Sci       Date:  1973-05       Impact factor: 3.534

2.  Creatinine assay by a reaction-kinetic principle.

Authors:  K Larsen
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

3.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

Review 4.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

5.  High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs.

Authors:  D W Warnock; M D Richardson; A Turner
Journal:  J Antimicrob Chemother       Date:  1982-12       Impact factor: 5.790

6.  Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.

Authors:  R B Diasio; D E Lakings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

7.  Pharmacological studies with 5-fluorocytosine.

Authors:  E R Block; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

8.  Bone marrow toxicity associated with 5-fluorocytosine therapy.

Authors:  C A Kauffman; P T Frame
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  8 in total
  4 in total

1.  Performance characteristics of two bioassays and high-performance liquid chromatography for determination of flucytosine in serum.

Authors:  G St-Germain; S Lapierre; D Tessier
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 2.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

3.  Simplified bioassay method for measurement of flucytosine or ketoconazole.

Authors:  C A Bodet; J H Jorgensen; D J Drutz
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

4.  Sarcosine oxidase: structure, function, and the application to creatinine determination.

Authors:  H Suzuki
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.